Journal of International Oncology
Efficacy of different treatment modalities in the real-world setting for advanced EGFR-mutant NSCLC patients after progression on third-generation EGFR-TKI treatment
Yang Junling, Zhang Guifang, Mu Zhuqing, Huang Puchao, Ma Xiaoyan, Liang Jiaxin
Journal of International Oncology . 2026, (4): 201 -206 .  DOI: 10.3760/cma.j.cn371439-20251015-00033